The series on “Locally Advanced Thymic Epithelial Tumors” is edited by Dr. Masatsugu Hamaji, MD, PhD, Department of General Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan. This series discuss the pathology, therapies, staging and evaluation of thymic epithelial tumors.
Masatsugu Hamaji, MD, PhD
Department of General Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan
Dr. Hamaji obtained his MD degree in Kyoto University Hospital in 2001 and PhD in Bioartificial Organ in Graduate Medical School of Kyoto University in 2016. Dr. Hamaji is a board-certified general thoracic surgeon and lecturer at Kyoto University Hospital.
He joined the faculty of General thoracic surgery at Kyoto University after he finished a two-year clinical fellowship of general thoracic surgery at the Mayo Clinic Rochester, MN and one-year clinical fellowship of minimally invasive thoracic surgery at Brigham and Women’s Hospital, Boston, MA, USA.
He has been involved in minimally invasive thoracic surgery and lung transplantation since 2016. His clinical and research interest includes thymic epithelial tumors, chest wall reconstruction, and extended resection for locally advanced non-small cell lung cancer.
Dr. Hamaji plays a humble but steady role in numerous organizations, including the member of Cardiothoracic Surgery Network, member of European Society of Thoracic Surgeons (ESTS), the Japanese Association for Thoracic Surgeons (JATS), the Japanese Association of Chest Surgeons (JACS), etc. He also authored a number of articles in the general thoracic surgical field, in collaboration with national and international institutions.
Series outline:
- Gene mutation of thymic carcinoma
- Pathology of locally advanced thymic epithelial tumors
- Postoperative radiotherapy for locally advanced thymic epithelial tumors
- Radiological findings of locally advanced epithelial tumors
- Perioperative management and postoperative outcomes
- Long-term outcomes in patients with locally advanced thymic epithelial tumors
- Re-staging and operative indications after induction therapy for thymic epithelial tumors
- Indication and management of induction therapy
- Lymph node evaluation for locally advanced thymic epithelial tumors
Disclosure:
The series “Locally Advanced Thymic Epithelial Tumors” was commissioned by the editorial office, Mediastinum without any sponsorship or funding. Dr. Masatsugu Hamaji is serving as the unpaid Guest Editor for the series and serves as an unpaid editorial board member of Mediastinum from May 2022 – April 2024.